Svoboda | Graniru | BBC Russia | Golosameriki | Facebook

The Emerging Role of "Liquid Biopsies," Circulating Tumor Cells, and Circulating Cell-Free Tumor DNA in Lung Cancer Diagnosis and Identification of Resistance Mutations. (Q39097813)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 2017

Language	Label	Description	Also known as
English	The Emerging Role of "Liquid Biopsies," Circulating Tumor Cells, and Circulating Cell-Free Tumor DNA in Lung Cancer Diagnosis and Identification of Resistance Mutations.	scientific article published on January 2017

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28110461%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

The Emerging Role of "Liquid Biopsies," Circulating Tumor Cells, and Circulating Cell-Free Tumor DNA in Lung Cancer Diagnosis and Identification of Resistance Mutations (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28110461%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

0 references

cancer diagnosis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Angela Esposito

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28110461%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Dario Trapani

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28110461%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

publication date

1 January 2017

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28110461%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Current Oncology Reports

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28110461%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28110461%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28110461%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28110461%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Reduced lung-cancer mortality with low-dose computed tomographic screening

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Liquid biopsies for solid tumors: Understanding tumor heterogeneity and real time monitoring of early resistance to targeted therapies.

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Intratumor heterogeneity: evolution through space and time

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Cell-free nucleic acids as biomarkers in cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Circulating deoxyribonucleic Acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Quantification of free circulating DNA as a diagnostic marker in lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Circulating DNA: diagnostic tool and predictive marker for overall survival of NSCLC patients

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage.

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Value of quantitative analysis of circulating cell free DNA as a screening tool for lung cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Plasma DNA quantification in lung cancer computed tomography screening: five-year results of a prospective study.

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Early Prediction of Response to Tyrosine Kinase Inhibitors by Quantification of EGFR Mutations in Plasma of NSCLC Patients.

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

The prognostic value of KRAS mutated plasma DNA in advanced non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Multi-purpose utility of circulating plasma DNA testing in patients with advanced cancers

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Noninvasive detection of response and resistance in EGFR-mutant lung cancer using quantitative next-generation genotyping of cell-free plasma DNA.

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M.

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case study.

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Equilibrium separation and filtration of particles using differential inertial focusing

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Highly sensitive enumeration of circulating tumor cells in lung cancer patients using a size-based filtration microfluidic chip

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Microcavity array system for size-based enrichment of circulating tumor cells from the blood of patients with small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

A microfluidic chip integrated with a high-density PDMS-based microfiltration membrane for rapid isolation and detection of circulating tumor cells.

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Circulating tumor cell as a diagnostic marker in primary lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

"Sentinel" circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Circulating Tumor Cells in Diagnosing Lung Cancer: Clinical and Morphologic Analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

The identification and characterization of breast cancer CTCs competent for brain metastasis

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Detection of mutations in EGFR in circulating lung-cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: toward a real-time liquid biopsy for treatment

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Development of a highly sensitive and specific method for detection of circulating tumor cells harboring somatic mutations in non-small-cell lung cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

ALK-gene rearrangement: a comparative analysis on circulating tumour cells and tumour tissue from patients with lung adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Detection of circulating tumor cells harboring a unique ALK rearrangement in ALK-positive non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Combined transcriptome and genome analysis of single micrometastatic cells

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Personalized medicine in a phase I clinical trials program: the MD Anderson Cancer Center initiative

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non–Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

High level of chromosomal instability in circulating tumor cells of ROS1-rearranged non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/28110461

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new device for rapid isolation by size and characterization of rare circulating tumor cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/28110461

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/28110461

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/28110461

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The origin and mechanism of circulating DNA

1 reference

https://pubmed.ncbi.nlm.nih.gov/28110461

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/28110461

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/28110461

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/28110461

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11912-017-0564-Y

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28110461%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28110461%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39097813&oldid=2202542081"